Jeffrey A. Meckler, Director at Travere Therapeutics, Inc. (TVTX), sold 40,000 shares at $14.06 ($562K) on 2024-09-30, disclosed to the SEC on 2024-09-30.
Scheduled sale ($562k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| INDP | BUY | 2022-11-22 | $19K | — | Filing → |
| INDP | BUY | 2022-09-12 | $29K | — | Filing → |
| INDP | BUY | 2022-09-08 | $25K | — | Filing → |